Dr. Catherine Alix-Panabières, winner of the Savchuk Prize!

, ,

On Thursday, January 27, 2022, Dr. Catherine Alix-Panabières received the prestigious Savchuk Prize at the 15th Cancer Research Biennial for her work on "liquid biopsies." A look back at 23 years of research in the field of cancer research.

A career focused on the development of liquid biopsy

Dr. Alix-Panabières, director of the Rare Human Circulating Cells (CCRH) laboratory at Montpellier University Hospital, has been dedicated to her research for 23 years. Invented by her in 2010 with her German colleague, Professor Klaus Pantel from Hamburg, the term "liquid biopsy," which complements tissue biopsy, refers to a blood test that is performed repeatedly during a patient's treatment.

 

A non-invasive procedure

Liquid biopsy provides access to circulating cells or elements that are released by the primary tumor or metastases. The advantage? It offers the possibility of studying tumors located in inaccessible areas, repeatedly and non-invasively. After taking a blood sample, this procedure provides information on the progression of the tumor and therefore on the treatment.

His research focuses on three fundamental aspects:

  1. Understanding the biology of the tumor and its destination.
  2. Technology: Dr. Alix-Panabières is working on a patent focused on this new technique for detecting circulating tumor cells.
  3. A translational clinical study. Liquid biopsy allows treatment to be tailored to each patient's stage, particularly when starting treatment.

We extend our warmest congratulations to Dr. Catherine Alix-Pananières on receiving this award!